Cemented vs. Non-Cemented TSA for OA of the Shoulder

Sponsor
Fowler Kennedy Sport Medicine Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT00158418
Collaborator
Zimmer Biomet (Industry)
160
1
72
2.2

Study Details

Study Description

Brief Summary

The purpose of the study is to investigate the fixation of the humeral component in total shoulder arthroplasty for primary osteoarthritis of the glenohumeral joint.Our hypothesis is that uncemented fixation of the humerus will result in better disease-specific quality of life, decreased incidence of radiographic loosening, decrease operative time and no increase in complications.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cemented Humeral Stem
  • Procedure: Uncemented Humeral Stem
Phase 3

Detailed Description

Currently, cement fixation of the humeral component is recommended as the standard of care and review of the literature indicates that this fixation is associated with a low complication rate. Uncemented fixation is promising in its potential to provide long-term, stable fixation yet comparative results to cemented stems are not available at this time.

Despite an absence of data to support their use, there has been an exponential increase in the use of uncemented humeral component fixation in shoulder arthroplasty. This push may be dictated by the desire to reduce operative time in an attempt to cut surgical expenses. This goal is particularly highlighted by the efforts of government and third party bodies to maximize return on limited funds. There is no conclusive clinical data at this time to suggest that uncemented fixation yields results that are better than cemented fixation in the shoulder.

This multi-centre, prospective, randomized double blinded clinical trial will compare cemented versus uncemented/tissue-ingrowth fixation of the humeral component in total shoulder arthroplasty. Patients are recruited from 10 centres across Canada by surgeons with extensive experience in total shoulder arthroplasty. Patients will be randomized to receive either a cemented or uncemented humeral stem. All other variables will be controlled for.

The main evaluation of patient outcome is disease-specific quality of life. Validated tools evaluating shoulder function are being used for this purpose, as required by various societies. These include the Western Ontario Osteoarthritis of the Shoulder Index (WOOS), the most responsive; Constant, preferred by European investigators; American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Assessment and Shoulder Score Index, preferred by the ASES. Overall global health status is measured using the SF-36. Several secondary outcomes are monitored for during the post-operative course. These are: shoulder function, radiographic evaluation of component fixation, operative time and the incidence of revision surgery and complications.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Cemented Versus Uncemented Fixation of Humeral Components in Total Shoulder Arthroplasty for Osteoarthritis of the Shoulder
Study Start Date :
Aug 1, 2002
Actual Primary Completion Date :
Aug 1, 2008
Actual Study Completion Date :
Aug 1, 2008

Outcome Measures

Primary Outcome Measures

  1. disease specific quality of life comparing the 2 groups at 2 years using several shoulder function rating scales. []

  2. the Western Ontario Osteoarthritis of the Shoulder Index (WOOS) []

  3. the Constant Score []

  4. American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Assessment form. []

  5. Short Form-12 []

Secondary Outcome Measures

  1. the evaluation of radiolucent lines indicative of implant loosening []

  2. the incidence of revision surgery complications []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Primary osteoarthritis of the shoulder of grade III or higher (Kellgren and Lawrence modified for the shoulder

  2. Patients who have failed standard conservative management of their shoulder osteoarthritis

Exclusion Criteria:
  1. Patients with secondary OA resulting from major joint trauma, infection, avascular necrosis, cuff tear arthropathy, chronic dislocation, massive rotator cuff tear, inflammatory arthropathy, Charcot's arthropathy or previous shoulder surgery (other than arthroscopic debridement)

  2. Patients with preoperative CT scans of the shoulder which show insufficient glenoid bone stock that would not allow for implantation of a glenoid prosthesis

  3. Active joint or systemic infection

  4. Significant muscle paralysis

  5. Major medical illness (life expectancy less then 2yrs or unacceptably high operative risk)

  6. Unable to speak or read English/French

  7. Psychiatric illness that precludes informed consent

  8. Unwilling to be followed for 2 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fowler Kennedy Sport Medicine Clinic London Ontario Canada N6A 3K7

Sponsors and Collaborators

  • Fowler Kennedy Sport Medicine Clinic
  • Zimmer Biomet

Investigators

  • Principal Investigator: Robert B Litchfield, MD, FRCSC, Fowler Kennedy Sport Medicine Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00158418
Other Study ID Numbers:
  • FKSMC-CIHR-2
  • UCT-137451
First Posted:
Sep 12, 2005
Last Update Posted:
Jan 29, 2009
Last Verified:
Sep 1, 2005
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2009